(Total Views: 614)
Posted On: 06/02/2020 8:43:18 AM
Post# of 155002
New 8K - Having an independent chairman for the nominating committee is a necessity for listing on the NYSE.
Quote:
On April 23, 2020, CytoDyn Inc. (the “Company”) filed a Current Report on Form 8-K to announce the appointment of a new independent director.
On May 27, 2020, the Board appointed Dr. Patel to the Board’s Nominating and Governance Committee as its chair.
(4)
(0)
